ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,096Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 387

$1.1M Total Retail Price of All Prescriptions

Rank: 26 out of 387

508 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 508 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,988 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 808 415 1 2
FUROSEMIDE 480 284 2 7
HYDROCODONE-ACETAMINOPHEN 461 256 S3 3 1
LISINOPRIL 438 276 4 3
OMEPRAZOLE 404 206 5 4
SIMVASTATIN 384 230 6 5
CITALOPRAM HBR 357 172 7 19
METFORMIN HCL 311 195 8 8
DILTIAZEM HCL 258 195 9 187
FENOFIBRATE 235 72 10 106
TRAMADOL HCL 199 87 11 14
GABAPENTIN 197 96 12 10
NAMENDA 194 106 13 35
ZOLPIDEM TARTRATE 194 76 13 16
MELOXICAM 192 98 15 22
PREDNISONE 190 102 16 43
RISPERIDONE 184 43 17 70
ALENDRONATE SODIUM 184 96 17 31
METOPROLOL TARTRATE 177 135 19 11
POTASSIUM CHLORIDE 160 100 20 9
PRAVASTATIN SODIUM 158 91 21 15
ATORVASTATIN CALCIUM 149 80 22 13
CEFDINIR 144 93 23 163
TAMSULOSIN HCL 142 110 24 32
DIVALPROEX SODIUM 138 69 25 113
CIPROFLOXACIN HCL 135 70 26 56
NYSTATIN 134 50 27 147
HYDROCHLOROTHIAZIDE 127 87 28 12
QUETIAPINE FUMARATE 126 34 29 88
AMLODIPINE BESYLATE 126 86 29 6
ESCITALOPRAM OXALATE 123 57 31 73
FLUOXETINE HCL 119 26 32 46
ABILIFY 118 0 33 129
POLYETHYLENE GLYCOL 3350 116 57 34 57
DONEPEZIL HCL 116 72 34 27
DIVALPROEX SODIUM ER 115 46 36 143
SERTRALINE HCL 109 36 37 23
WARFARIN SODIUM 109 95 37 17
BUSPIRONE HCL 108 92 39 121
OLANZAPINE 104 42 40 126
MORPHINE SULFATE ER 103 29 S2 41 79
ALLOPURINOL 102 67 42 28
RANITIDINE HCL 101 40 43 45
CLONIDINE HCL 99 50 44 38
FLUTICASONE PROPIONATE 97 47 45 29
CARBAMAZEPINE 96 13 46 238
PROPRANOLOL HCL 96 54 46 100
CARISOPRODOL 93 0 R 48 53
CYCLOBENZAPRINE HCL 92 27 R 49 42
CARVEDILOL 92 56 49 21
PHENYTOIN SODIUM EXTENDED 91 12 51 107
KLOR-CON M20 90 29 52 76
METOPROLOL SUCCINATE 85 61 53 18
FLUVOXAMINE MALEATE 85 14 53 316
CYMBALTA 82 18 55 44
PANTOPRAZOLE SODIUM 80 47 56 48
CLOPIDOGREL 80 61 56 25
PROMETHAZINE HCL 77 20 R 58 82
LANTUS 77 61 58 51
BENZTROPINE MESYLATE 76 0 R 60 167
IBUPROFEN 76 49 60 85
LOPERAMIDE 74 13 62 181
OXYCODONE HCL 74 17 S2 62 71
OXYCONTIN 72 14 S2 64 92
ATENOLOL 71 48 65 20
LEVOFLOXACIN 70 49 66 84
AZITHROMYCIN 70 32 66 49
PAROXETINE HCL 66 13 68 52
NEXIUM 64 40 69 26
TRIAMTERENE-HCTZ 64 56 69 55
ADVAIR DISKUS 62 30 71 41
TRICOR 60 56 72 145
OXYBUTYNIN CHLORIDE ER 60 18 72 120
DILANTIN 59 0 74 287
PROAIR HFA 57 0 75 47
OXCARBAZEPINE 57 43 75 245
SEROQUEL 57 25 75 174
GLIPIZIDE 56 36 78 63
CARBAMAZEPINE XR 56 13 78 294
PLAVIX 56 48 78 39
TRAZODONE HCL 52 22 81 37
TRIAMCINOLONE ACETONIDE 52 14 81 159
DIGOXIN 51 31 83 40
LOVASTATIN 50 31 84 36
CLOZAPINE 50 0 84 185
AMOX TR-POTASSIUM CLAVULANATE 50 17 84 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.